Relating to the establishment of a consortium to conduct United States Food and Drug Administration's drug development clinical trials with ibogaine to secure the administration's approval of the medication's use for treatment of opioid use disorder, co-occurring substance use disorder, and any other neurological or mental health conditions for which ibogaine demonstrates efficacy and to the administration of that treatment.

Signed by the Governor

Effective immediately

Sent to the Governor

Reported enrolled

Signed in the Senate

Signed in the House

House adopts conf. comm. report-reported

Record vote

Statement(s) of vote recorded in Journal

House adopts conference committee report

House adopts resolution to go outside bounds

Senate adopts conf. comm. report-reported

Record vote

Senate adopts conference committee report

Senate adopts resolution to go outside bounds

Conf. Comm. Report distributed

Conference committee report filed

House appoints conferees-reported

House grants request for conf comm-reported

House appoints conferees

House grants request for conference committee

Senate appoints conferees-reported

Senate requests conference committee-reported

Senate refuses to concur-reported

Senate appoints conferees

Senate requests conference committee

Senate refuses to concur

Read

House amendment(s) laid before the Senate

House passage as amended reported

Statement(s) of vote recorded in Journal

Record vote

Passed

Read 3rd time

Record vote

Comte report filed with Committee Coordinator

Committee report distributed

Committee report sent to Calendars

Laid out in lieu of companion

Read 2nd time

Amended

Passed to 3rd reading as amended

Statement(s) of vote recorded in Journal

Reported favorably as substituted

Committee substitute considered in committee

Considered in formal meeting

Referred to Public Health

Read first time

Received from the Senate

Reported engrossed

Passed

Read 3rd time

Three day rule suspended

Read 2nd time & passed to engrossment

Record vote

Rules suspended-Regular order of business

Placed on intent calendar

Co-author authorized

Committee report printed and distributed

Reported favorably w/o amendments

Vote taken in committee

Considered in public hearing

Left pending in committee

Testimony taken in committee

Considered in public hearing

Scheduled for public hearing on . . .

Referred to Health & Human Services

Read first time

Filed

Received by the Secretary of the Senate